{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T16:26:25Z","timestamp":1787243185021,"version":"build-2736575974"},"reference-count":48,"publisher":"SAGE Publications","issue":"3","license":[{"start":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T00:00:00Z","timestamp":1775692800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"crossref","award":["JP25am0521010 (to Y.K.), JP25ama121008 (to Y.K.),"],"award-info":[{"award-number":["JP25am0521010 (to Y.K.), JP25ama121008 (to Y.K.),"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Monoclonal Antibodies in Immunodiagnosis &amp; Immunotherapy"],"published-print":{"date-parts":[[2026,6]]},"abstract":"<jats:p>\n                    Cadherin-5 (CDH5), also known as vascular endothelial cadherin (VE-cadherin), plays crucial roles in endothelial cell adhesion, vascular barrier function, and signaling. CDH5 manages endothelial cell\u2013cell junctions during vascular remodeling, which is vital for both vascular homeostasis and adaptive responses to pathological stimuli. Although anti-CDH5 monoclonal antibodies (mAbs) are used for specific applications such as flow cytometry, Western blotting, and immunohistochemistry (IHC), highly sensitive and versatile anti-CDH5 mAbs suitable for all these applications remain limited. Here, new anti-human CDH5 mAbs, called Ca\n                    <jats:sub>5<\/jats:sub>\n                    Mabs, were developed through a flow cytometry-based high-throughput screening. Among them, clone Ca\n                    <jats:sub>5<\/jats:sub>\n                    Mab-8 (mouse IgG\n                    <jats:sub>2a<\/jats:sub>\n                    , kappa) recognized CDH5-overexpressed Chinese hamster ovary-K1 (CHO\/CDH5) cells in flow cytometry. Moreover, Ca\n                    <jats:sub>5<\/jats:sub>\n                    Mab-8 also recognized endogenous CDH5-expressing human endothelial cell lines (HUVEC\/TERT2 and HDMVEC\/TERT164-B) and a cervical cancer cell line (HeLa). These reactivities exceeded those of a commercial anti-CDH5 mAb (clone BV9). The apparent dissociation constant of Ca\n                    <jats:sub>5<\/jats:sub>\n                    Mab-8 for CHO\/CDH5 was measured as 6.1 \u00d7 10\n                    <jats:sup>\u22129<\/jats:sup>\n                    M. Ca\n                    <jats:sub>5<\/jats:sub>\n                    Mab-8 can detect endogenous CDH5 in Western blotting. In addition, Ca\n                    <jats:sub>5<\/jats:sub>\n                    Mab-8, but not BV9, can be used for IHC to detect endothelial cells in formalin-fixed paraffin-embedded tissues. These findings suggest that Ca\n                    <jats:sub>5<\/jats:sub>\n                    Mab-8 is a versatile basic research tool in vascular biology and has potential for clinical applications including tumor diagnosis and therapy.\n                  <\/jats:p>","DOI":"10.1177\/21679436261441142","type":"journal-article","created":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T14:42:21Z","timestamp":1775745741000},"page":"34-44","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":0,"title":["A Novel Anti-CDH5\/VE-Cadherin Monoclonal Antibody (Ca\n                    <sub>5<\/sub>\n                    Mab-8) for Flow Cytometry, Western Blotting, and Immunohistochemistry"],"prefix":"10.1177","volume":"45","author":[{"given":"Haruto","family":"Yamamoto","sequence":"first","affiliation":[{"name":"Department of Antibody Drug Development, Tohoku University Graduate School of Medicine, Sendai, Miyagi, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Department of Antibody Drug Development, Tohoku University Graduate School of Medicine, Sendai, Miyagi, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mika K.","family":"Kaneko","sequence":"additional","affiliation":[{"name":"Department of Antibody Drug Development, Tohoku University Graduate School of Medicine, Sendai, Miyagi, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5385-8201","authenticated-orcid":false,"given":"Yukinari","family":"Kato","sequence":"additional","affiliation":[{"name":"Department of Antibody Drug Development, Tohoku University Graduate School of Medicine, Sendai, Miyagi, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2026,4,9]]},"reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2023.1234104"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrc3647"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2023.1137013"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrm3431"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1242\/jcs.124529"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00035.2003"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1097\/MOH.0b013e3283523e1c"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.01847"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1160\/th14-04-0299"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.2011.01808.x"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.200408130"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24119343"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.94.12.6273"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-023-04801-z"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tcm.2005.11.008"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.201408103"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature03952"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1007\/s13105-025-01106-6"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpcell.00605.2023"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a003129"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2009.05.033"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.v97.6.1679"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.v100.3.905"},{"issue":"24","key":"e_1_3_3_25_2","first-page":"6805","article-title":"Monoclonal antibody to vascular endothelial-cadherin is a potent inhibitor of angiogenesis, tumor growth, and metastasis","volume":"60","author":"Liao F","year":"2000","unstructured":"Liao F, , Li Y, , O\u2019Connor W, et al. Monoclonal antibody to vascular endothelial-cadherin is a potent inhibitor of angiogenesis, tumor growth, and metastasis. Cancer Res, 2000; 60(24):6805\u20136810.","journal-title":"Cancer Res"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrep.2025.102401"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrep.2025.102138"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pep.2014.01.009"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1089\/mab.2016.0039"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1177\/21679436261428408"},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.36922\/MI025220049"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.18632\/aging.206061"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0158395"},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2023.02.016"},{"key":"e_1_3_3_35_2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1367875"},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcancer.2023.04.007"},{"key":"e_1_3_3_37_2","doi-asserted-by":"publisher","DOI":"10.1172\/jci84876"},{"key":"e_1_3_3_38_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.96.17.9815"},{"issue":"9","key":"e_1_3_3_39_2","first-page":"2567","article-title":"Selective targeting of angiogenic tumor vasculature by vascular endothelial-cadherin antibody inhibits tumor growth without affecting vascular permeability","volume":"62","author":"Liao F","year":"2002","unstructured":"Liao F, , Doody JF, , Overholser J, et al. Selective targeting of angiogenic tumor vasculature by vascular endothelial-cadherin antibody inhibits tumor growth without affecting vascular permeability. Cancer Res, 2002; 62(9):2567\u20132575.","journal-title":"Cancer Res"},{"key":"e_1_3_3_40_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-025-02299-4"},{"key":"e_1_3_3_41_2","doi-asserted-by":"publisher","DOI":"10.3390\/cells14060407"},{"key":"e_1_3_3_42_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature09624"},{"key":"e_1_3_3_43_2","doi-asserted-by":"publisher","DOI":"10.1186\/s40478-025-02031-x"},{"key":"e_1_3_3_44_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature09557"},{"key":"e_1_3_3_45_2","doi-asserted-by":"publisher","DOI":"10.1089\/mab.2023.0033"},{"key":"e_1_3_3_46_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.str.2024.02.007"},{"key":"e_1_3_3_47_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.stem.2025.05.007"},{"key":"e_1_3_3_48_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26178302"},{"key":"e_1_3_3_49_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25031941"}],"container-title":["Monoclonal Antibodies in Immunodiagnosis &amp; Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/21679436261441142","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/21679436261441142","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/21679436261441142","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T15:57:04Z","timestamp":1787241424000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/21679436261441142"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,9]]},"references-count":48,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["10.1177\/21679436261441142"],"URL":"https:\/\/doi.org\/10.1177\/21679436261441142","relation":{},"ISSN":["2167-9436","2167-9436"],"issn-type":[{"value":"2167-9436","type":"print"},{"value":"2167-9436","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,9]]}}}